Panacea Biotec presents book PREVENT - Diabetes & Complications in India: Perspectives & Treatment Options
Panacea Biotec Ltd has informed BSE that Panacea Biotec, India's 3rd largest biotechnology Company has presented a book viz. PREVENT - Diabetes & Complications in India: Perspective & Treatment Options.PREVENT, 1st time in India, is a book which attempts to address management guidelines of diabetes and complications based on Indian perspective.... Panacea Biotec Signs agreement with Laboratorios Clausen, SA
Panacea Biotec Ltd has informed BSE the Company has entered into an agreement with Laboratorios Clausen, Uruguay for grant of non-exclusive marketing rights of the Company's medicine "Tacrolimus (Pangraph)" for few markets in Europe.The Company has submitted to BSE a copy of the Press Release in this regard.Press Release:"Panacea Biotec Ltd, India's 3rd largest biotech Company has signed a non-exclusive marketing agreement... Panacea Biotec redeems Foreign Currency Convertible Bonds (FCCBs)
Panacea Biotec Ltd has informed BSE regarding a Press Release dated February 15, 2011 titled "Panacea Biotec redeems Foreign Currency Convertible Bonds (FCCBs)"Press Release:"Panacea Biotech, the 3rd largest biotech Company of India, today announced that on February 14, 2011, it has redeemed the entire outstanding Zero Coupon Convertible Bonds (Tranche 2) along with the accumulated redemption premium. Thus the Tranche 2 Bonds have... Panacea Biotec Launches - PacliALL
Panacea Biotec Ltd has informed BSE regarding a Press Release dated February 10, 2011 titled "Panacea Biotec Launches - PacliALL".Press Release:"Panacea Biolec, India's 3rd largest biolechnology company is planning to introduce during Indian Cancer Congress 2011 at Bhubaneswar on Feb 12, 2011; their indigenously developed Albumin bound Paclitaxel particles formulation. - PacliALL.... Limited Review for the quarter ended Dec 31, 2010
Panacea Biotec Ltd has informed BSE that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended December 31, 2010. Results Press Release
Panacea Biotec Ltd has informed BSE regarding a Press Release dated January 28, 2011 titled " Panacea Biotec reports impressive financial results". Financial Results for Dec 31, 2010
Panacea Biotec Ltd has informed BSE about the Financial Results for the Quarter ended December 31, 2010 Outcome of Board Meeting
Panacea Biotec Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 28, 2011, inter alia, has approved the proposed redemption of outstanding Zero Coupon Convertible Bonds worth 36.8 million on their maturity date i.e. February 14, 2011. Board Meeting on Jan 28, 2011
Panacea Biotec Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 28, 2011, inter-alia, to consider the following:1. To consider and approve the Unaudited Financial Results (Provisional) for the quarter as well as nine months ended December 31, 2010.2. To redemption of outstanding Zero Coupon Convertible Bonds aggregating USD 36.8 million, due for redemption on February 14, 2011. Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 1997
Panacea Biotec Ltd has submitted the disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE: